Tesaro, Inc. Announces Election of Dr. James Armitage to Board of Directors and Results of Annual Stockholder Meeting

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WALTHAM, Mass., May 9, 2013 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO), an oncology-focused biopharmaceutical company, today announced that James O. Armitage, M.D., F.A.C.P., F.R.C.P., has been elected to the TESARO Board of Directors. This election increases the number of independent directors on the Company's Board to six.

Help employers find you! Check out all the jobs and post your resume.

Back to news